Literature DB >> 24272507

The molecular basis for the mode of action of Beta-lactam antibiotics and mechanisms of resistance.

B W Bycroft1, R E Shute.   

Abstract

This review on the molecular basis for the mode of action of β-lactam antibiotics and mechanisms of resistance is divided into three main sections. Firstly, a brief introduction to the β-lactam antibiotic family is presented from the standpoint of their natural product origins. The second section is concerned with bacterial cell wall structure and biosynthesis, and the mode of action of β-lactam antibiotics. It includes an attempted rationalization of the multiple enzyme targets of penicillin, the so-called "penicillin binding proteins", into one or two lethal sites of action and the interaction of these enzymes with β-lactams in terms of their analogy to the natural substrate and to the substrate-enzyme transition state. The final part covers the phenomenon of bacterial resistance to β-lactam antibiotic therapy and deals with the two most important manifestations of resistance; permeability and the production of β-lactamases. This latter more crucial factor is then expanded with particular reference to the irreversible inhibition of these enzymes by suicide inactivators; a general theory for irreversible β-lactamase inhibition is discussed and the future prospects within this whole area are briefly overviewed.

Entities:  

Year:  1985        PMID: 24272507     DOI: 10.1023/A:1016305704057

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  74 in total

1.  Mode of action of penicillin.

Authors:  J T PARK; J L STROMINGER
Journal:  Science       Date:  1957-01-18       Impact factor: 47.728

2.  Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

Authors:  C Reading; M Cole
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

3.  The semi-synthetic thienamycin derivative MK0787 and its properties with respect to a range of beta-lactamases from clinically relevant bacterial species.

Authors:  M H RIchmond
Journal:  J Antimicrob Chemother       Date:  1981-03       Impact factor: 5.790

4.  Mutual pro-drugs of beta-lactam antibiotics and beta-lactamase inhibitors.

Authors:  B Baltzer; E Binderup; W von Daehne; W O Godtfredsen; K Hansen; B Nielsen; H Sørensen; S Vangedal
Journal:  J Antibiot (Tokyo)       Date:  1980-10       Impact factor: 2.649

5.  ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type.

Authors:  B Jaurin; T Grundström
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

Review 6.  The mechanism of the irreversible antimicrobial effects of penicillins: how the beta-lactam antibiotics kill and lyse bacteria.

Authors:  A Tomasz
Journal:  Annu Rev Microbiol       Date:  1979       Impact factor: 15.500

7.  Sch 29482, laboratory evaluation of a new penem antibiotic.

Authors:  F H Kayser; I Kuhn
Journal:  J Antimicrob Chemother       Date:  1982-02       Impact factor: 5.790

8.  Inhibition of the RTEM beta-lactamase from Escherichia coli. Interaction of the enzyme with derivatives of olivanic acid.

Authors:  C J Easton; J R Knowles
Journal:  Biochemistry       Date:  1982-06-08       Impact factor: 3.162

9.  Properties of the penicillin-binding proteins of Escherichia coli K12,.

Authors:  B G Spratt
Journal:  Eur J Biochem       Date:  1977-01

10.  Kinetic studies on the inactivation of Escherichia coli RTEM beta-lactamase by clavulanic acid.

Authors:  J Fisher; R L Charnas; J R Knowles
Journal:  Biochemistry       Date:  1978-05-30       Impact factor: 3.162

View more
  4 in total

Review 1.  Instructive Advances in Chemical Microbiology Inspired by Nature's Diverse Inventory of Molecules.

Authors:  Ke Liu; Robert W Huigens
Journal:  ACS Infect Dis       Date:  2020-01-06       Impact factor: 5.084

2.  Interactions of a synthetic Leu-Lys-rich antimicrobial peptide with phospholipid bilayers.

Authors:  David I Fernandez; Marc-Antoine Sani; John D Gehman; Kyung-Soo Hahm; Frances Separovic
Journal:  Eur Biophys J       Date:  2011-01-12       Impact factor: 1.733

3.  The Molecular Basis of β-Lactamase Catalysis and Inhibition.

Authors:  A L Fink
Journal:  Pharm Res       Date:  1985-03       Impact factor: 4.200

4.  Antibiotic Azithromycin inhibits brown/beige fat functionality and promotes obesity in human and rodents.

Authors:  Jian Yu; Xin Chen; Yuanjin Zhang; Xiangdi Cui; Zhe Zhang; Wenxiu Guo; Dongmei Wang; Shengbo Huang; Yanru Chen; Yepeng Hu; Cheng Zhao; Jin Qiu; Yu Li; Meiyao Meng; Mingwei Guo; Fei Shen; Mengdi Zhang; Ben Zhou; Xuejiang Gu; Jiqiu Wang; Xin Wang; Xinran Ma; Lingyan Xu
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.